Status:
COMPLETED
Atrial Fibrillation Screening and Education Study
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Heart Rhythm Society
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the outcomes of a community placed atrial fibrillation (AF) screening and education program
Detailed Description
Background/significance: Atrial fibrillation (AF) is a global epidemic that accounts for 15%-20% of 795,000 strokes occurring annually in the US, at a cost of $3.2 billion per year. Atrial fibrillatio...
Eligibility Criteria
Inclusion
- Inclusion :
- Any two of the following:
- Hypertension
- Diabetes
- Sleep apnea
- Obesity
- Age \> 75 years
- Peripheral arterial disease
- Female
- Exclusion :
- Previous diagnosis of atrial fibrillation or atrial flutter
- Uncompensated visual impairment
- Uncompensated hearing impairment
- Inability to communicate verbally in English
Exclusion
Key Trial Info
Start Date :
August 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 27 2019
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT03440762
Start Date
August 16 2017
End Date
August 27 2019
Last Update
September 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905